1. Profile of Silodosin European Urology Supplements
Francesco Montorsi 
European Urology Supplements 
Volume 9, Issue 4, Pages (July 2010)
DOI: /j.eursup
Copyright © 2010 European Association of Urology Terms and Conditions

2. Fig. 1
Percentage of patients with reduction of at least one episode of nocturia (placebo=148; silodosin=308; tamsulosin=308).
* p<0.05 versus placebo.
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

3. Fig. 2
Percentage of patients with simultaneous improvement in incomplete emptying, frequency, and nocturia (patient population and subgroup with two or more episodes of nocturia).
§ p=0.02 versus placebo; p=0.03 versus tamsulosin.
# p=0.04 versus placebo; p=0.03 versus tamsulosin.
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions